|
Cardiac - pharmacology
Contributing journals to this collection:
Annals of Thoracic Surgery,
European Journal of Cardio-Thoracic Surgery,
Asian Cardiovascular & Thoracic Annals,
Journal of Thoracic and Cardiovascular Surgery,
Cardiac Surgery in the Adult,
and Interactive CardioVascular and Thoracic Surgery
Citations 511-520 of 599 total displayed.
- Original articles
The effect of chronic L-arginine administration on vascular recovery following cold cardioplegic arrest in rats
- Koki Nakamura, Ilona Schmidt, Caroline C. Gray, Ann Dewar, Steve Rothery, Nicholas J. Severs, Magdi H. Yacoub, and Mohamed Amrani
Eur. J. Cardiothorac. Surg. 2002; 21: 753-759.
[Abstract]
[Full text]
[PDF]
- Original articles
Amiodarone versus digoxin and metoprolol combination for the prevention of postcoronary bypass atrial fibrillation
- Hilmi Tokmakoglu, Ozer Kandemir, Serdar Gunaydin, Zeki Catav, Cem Yorgancioglu, and Yaman Zorlutuna
Eur. J. Cardiothorac. Surg. 2002; 21: 401-405.
[Abstract]
[Full text]
[PDF]
- CARDIOPULMONARY SUPPORT AND PHYSIOLOGY (CSP)
Does tranexamic acid reduce desmopressin-induced hyperfibrinolysis?
- Ertugrul Özal, Erkan Kuralay, Hakan Bingöl, Faruk Cingöz, Süleyman Ceylan, and Harun Tatar
J. Thorac. Cardiovasc. Surg. 2002; 123: 539-543.
[Abstract]
[Full text]
[PDF]
- CARDIOPULMONARY SUPPORT AND PHYSIOLOGY (CSP)
Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery
- John H. Lemmer, Jr and George J. Despotis
J. Thorac. Cardiovasc. Surg. 2002; 123: 213-217.
[Abstract]
[Full text]
[PDF]
- CARDIOPULMONARY SUPPORT AND PHYSIOLOGY (CSP)
Benefits of prophylactic continuous infusion of furosemide after the maze procedure for atrial fibrillation
- Niv Ad, Johan P. Suyderhoud, Young D. Kim, Martin A. Makary, Kerry W. DeGroot, Henry C. Lue, Eugen A. Pirovic, Weijia Z. Duvall, and James L. Cox
J. Thorac. Cardiovasc. Surg. 2002; 123: 232-236.
[Abstract]
[Full text]
[PDF]
- SURGERY FOR ACQUIRED CARDIOVASCULAR DISEASE (ACD)
Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections
- R. Finkelstein, G. Rabino, T. Mashiah, Y. Bar-El, Z. Adler, V. Kertzman, O. Cohen, and S. Milo
J. Thorac. Cardiovasc. Surg. 2002; 123: 326-332.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Successful use of activated recombinant factor VII to control bleeding abnormalities in a patient with a left ventricular assist device
- Miroslaw Garlicki, Jerzy Domagala, Karol Wierzbicki, Rafal Drwila, Roman Pfitzner, and Antoni Dziatkowiak
J. Thorac. Cardiovasc. Surg. 2002; 123: 384-385.
[Extract]
[Full text]
[PDF]
- CARDIOLOGY
Losartan in the Therapy of Heart Failure Patients
- Alexander E Berezin
Asian Cardiovasc Thorac Ann 2001; 9: 302-307.
[Abstract]
[Full text]
[PDF]
- CARDIOPULMONARY SUPPORT AND PHYSIOLOGY (CSP)
Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting
- Federico Bizzarri, Sabino Scolletta, Enrico Tucci, Mara Lucidi, Giuseppe Davoli, Thomas Toscano, Eugenio Neri, Luigi Muzzi, and Giacomo Frati
J. Thorac. Cardiovasc. Surg. 2001; 122: 1181-1185.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II
- Andreas Koster, Oliver Meyer, Thomas Fischer, Marian Kukucka, Thomas Krabatsch, Matthias Bauer, Herman Kuppe, and Roland Hetzer
J. Thorac. Cardiovasc. Surg. 2001; 122: 1254-1255.
[Extract]
[Full text]
[PDF]
|
|
